To address this gap, we conduct rigorous validation through in vitro experiments and use substantial datasets from TCGA, GTEx, CCLE, and GEO, allowing for a comprehensive examination of GRB7 expression patterns in ovarian cancer and their correlation with prognosis. The gene discussed is GRB7; the disease is ovarian cancer.